Gene therapy/bone marrow transplantation in ADA-deficient mice: roles of enzyme-replacement therapy and cytoreduction

Gene therapy (GT) for adenosine deaminase–deficient severe combined immune deficiency (ADA-SCID) can provide significant long-term benefit when patients are given nonmyeloablative conditioning and ADA enzyme-replacement therapy (ERT) is withheld before autologous transplantation of γ-retroviral vect...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Carbonaro, Denise A., Jin, Xiangyang, Wang, Xingchao, Yu, Xiao-Jin, Rozengurt, Nora, Kaufman, Michael L., Wang, Xiaoyan, Gjertson, David, Zhou, Yang, Blackburn, Michael R., Kohn, Donald B.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society of Hematology 2012
Konular:
Gene Therapy
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3488883/
https://ncbi.nlm.nih.gov/pubmed/22833548
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2012-02-408591
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller